Search Results 791-800 of 14767 for anti-TNF drugs

1. Peginterferon Alfa-2a (Subcutaneous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. Development of PARP Inhibitors and DDR Modifiers To Treat Ovarian Cancer - Anticancer Drug Action Laboratory - Mayo Clinic Research

   Dr. Kaufmann and his team in the Anticancer Drug Action Lab at Mayo Clinic are studying the susceptibility of HR-deficient cancer cells to PARP inhibitors ...

3. Trastuzumab And Hyaluronidase-Oysk (Subcutaneous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

   ... TNF] agents) within 4 weeks prior to cycle 1, day ... drugs); replacement therapy ... A stable regimen of highly active anti-retroviral therapy (HAART) ...

5. Colistin, Neomycin, Thonzonium, And Hydrocortisone (Otic Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Coly-Mycin S; Cortisporin TC. Canadian Brand Name.

6. Teriflunomide (Oral Route) Precautions - Mayo Clinic

   Women will receive a pregnancy test before starting this medicine. Use an effective form of birth control to keep from getting pregnant during treatment and ...

7. Abciximab (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. Overview - Rheumatology - Mayo Clinic Research

   Vasculitis — giant cell arteritis, anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and all other forms of vasculitis. Systemic autoimmune ...

9. Remifentanil (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

10. Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer - Mayo Clinic

    ... anti-cancer therapy or experimental agent concurrently with the study drugs. Any surgery must have been completed ≥ 4 weeks prior to starting study treatment.